• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL STENT - VASCULAR RECONSTRUCTION; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL STENT - VASCULAR RECONSTRUCTION; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number UNKENTERPRISE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 12/03/2012
Event Type  Injury  
Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4).This complaint is from a literature source and the following citation was reviewed: jia j, lv x, liu a, wu z, li y.Enterprise stent-assisted coiling of wide-necked intracranial aneurysms: clinical and angiographic follow-up.Interv neuroradiol.2012 dec;18(4):426-31.Doi: 10.1177/159101991201800408.Epub 2012 dec 3.Pmid: 23217637; pmcid: pmc3520556.Section d.4: the product catalog and lot numbers are not available / not reported.The unique identifier (udi) and expiration date of the device is not known.Section e.1: initial reporter facility name: (b)(6) institute and (b)(6) hospital.Section e.1: the initial reporter phone is not available / reported.Section h.4: the device manufacture date is not known as the device lot number is not available / not reported.Although no specific intervention is stated, it is clinically reasonable to assume an intervention would be provided in the case of an occlusion at/near the stent site.Each listed event is being reported to the us fda as a conservative measure.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Event Description
This complaint is from a literature source and the following citation was reviewed: jia j, lv x, liu a, wu z, li y.Enterprise stent-assisted coiling of wide-necked intracranial aneurysms: clinical and angiographic follow-up.Interv neuroradiol.2012 dec;18(4):426-31.Doi: 10.1177/159101991201800408.Epub 2012 dec 3.Pmid: 23217637; pmcid: pmc3520556.Methods: from april 2009 to october 2011, 604 consecutive patients with a total of 670 cerebral aneurysms underwent endovascular coil em-bolization procedure at our institution.Of these,169 patients (182 wide-necked aneurysms) underwent an attempted sace procedure.A wide-necked aneurysm was defined as having an angiographically measured dome-neck ratio of <1.5 mm or a neck that was =4 mm.Three of the 182 aneurysms were not stented (3/182, 1.6%) due to technical difficulties.Ultimately 166 patients with 179 cerebral aneurysms were treated with the placement of the enterprise stent.Concomitant cerenovus devices that were used in this study: enterprise stents concomitant non-cerenovus devices that were also used in this study: n/a adverse event(s) and provided interventions categorized as procedure-related complications for unknown enterprise stent 62 yo female sah r-pcom 3 mm experienced qty 1 in-stent thrombosis.30 yo male headache basilar trunk 18 mm experienced in-stent thrombosis.59 yo female tia l-ophthalmic 6 mm experienced in-stent thrombosis l- pcom 3 mm.66 yo female cn palsy r-pcom 4 mm experienced in-stent thrombosis l-vertebral 11 mm.40 yo female cn palsy l-ophthalmic 7 mm experienced in-stent thrombosis.71 yo male tia r-pcom 3 mm experienced asymptomatic stenosis.60 yo female headache l-ophthalmic 4 mm experienced aneurysm perforation that resulted in death.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STENT - VASCULAR RECONSTRUCTION
Type of Device
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
Manufacturer (Section G)
CERENOVUS, INC.
325 paramount dr.
raynham MA 02767
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
303552-689
MDR Report Key16969628
MDR Text Key315657134
Report Number3008114965-2023-00329
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
H60001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 05/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/19/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKENTERPRISE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/04/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ENTERPRISE STENTS
Patient Outcome(s) Life Threatening;
-
-